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Abstract 
Introduction 
It has been demonstrated that a pathway-based feature selection method which 
incorporates biological information within pathways into the process of feature 
selection usually outperform a gene-based feature selection algorithm in terms of 
predictive accuracy, stability, and biological interpretation. Significance analysis of 
microarray-gene set reduction algorithm (SAMGSR), an extension to a gene set 
analysis method with further reduction of the selected pathways to their respective 
core subsets, can be regarded as a pathway-based feature selection method. 
 
Results and Discussion  
In SAMGSR, whether a gene is selected is mainly determined by its expression 
difference between the phenotypes, and partially by the number of pathways to which 
this gene belongs, but ignoring the topology information among pathways. In this 
study, we propose a weighted version of the SAMGSR algorithm by constructing 
weights based on the connectivity among genes and then incorporating these weights 
in the test statistic.  
Conclusions 
Using both simulated and real-world data, we evaluate the performance of the 
proposed SAMGSR extension and demonstrate that gene connectivity is indeed 
informative for feature selection. 
  
Keywords: Pathway knowledge; pathway-based feature selection; significance 
analysis of microarray (SAM); weighted gene expression profiles; non-small cell lung 
cancer (NSCLC); multiple sclerosis (MS). 
 
Introduction 
Many researches have demonstrated that pathway-based feature selection 
algorithms, which utilize biological information contained in pathways to guide which 
features/genes should be selected, is usually superior to traditional gene-based feature 
selection algorithms in terms of predictive accuracy, stability, and biological 
interpretation [1–10]. Consequently, pathway-based feature selection algorithms have 
become increasingly popular and widespread.  
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Methods to incorporate pathway knowledge in feature selection algorithms can 
be classified into three categories – penalty, stepwise forward, and weighting. Their 
definitions and characteristics are presented in Figure 1. In the penalty category, an 
additional penalty term accounting for the pathway structure is added to the objective 
function for optimization. In essence, this penalty term provides some smoothness on 
nearby genes within a pathway, relying on the assumption that neighboring genes 
inside a pathway are more likely to function together or to be involved in the same 
biological process than those are far away. As a result, the ‘driving’ genes with subtle 
changes themselves but altering some of their neighbors’ expression values 
dramatically are more likely to be selected. However, the theoretical complexity and 
computational intensity associated with penalization methods require special 
attention.  
The second category of methods involve starting from one gene (e.g., the most 
significantly differentially expressed), and then adding genes gradually and evaluating 
on some statistic until no further gain upon this statistic can be obtained. For instance, 
the SAMGSR algorithm proposed by [11] belongs to this category, and it consists of 
two steps. Its first step is essentially an extension of SAM method [12] to all genes 
inside a pathway and the significance level of a pathway is determined using 
permutation tests. Then a core subset is extracted from each significant pathway 
identified by the first step using the magnitudes of individual genes’ SAM statistics. 
Given that SAMGSR is based on two well-established techniques, i.e., SAM and 
permutation test, its real-world applications are expected to be numerous. 
Nevertheless, SAMGSR implicitly accounts for pathway knowledge by increasing the 
chance of those genes involved in many pathways being selected, which ignores 
pathway topology information. Most importantly, SAMGSR may miss those ‘driving’ 
genes with subtle change because the crucial criterion for a gene’s inclusion in the 
reduced subsets is its gene expression difference between two phenotypes.  
The third category is to create a pathway knowledge-based weight for each gene. 
For instance, the reweighted recursive feature elimination (RRFE) algorithm proposed 
by Johannes et al [13] used GeneRank [14] to calculate a rank for each gene and then 
weighed the coefficients before a support vector machine (SVM) model by this rank. 
It had been demonstrated that the resulting gene signatures have better stability and 
more meaningful biological interpretation[13]. Compared to the other two categories, 
while the weighting category is more straightforward, it has been underutilized. Its 
underutilization might be due to the estimated weights are subject to errors and biases 
where the impact on the resulting significant may be substantial.   
In this study, we propose a hybrid method that combines SAMGSR with a 
pathway topology-based weight to carry out feature selection. As a mixture of the 
weighting method and stepwise forward method, the objective is to address some 
disadvantages associated with SAMGSR and the weighting method while borrowing 
their strengths. The proposed method is referred to as weighted-SAMGSR herein. 
Applying it to both the simulated data and real-world application, we evaluate if the 
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weight reflecting gene connectivity information is valuable for feature selection.   
Materials and Methods 
Experimental Data  
We considered two sets of microarray datasets in this study. One is for multiple 
sclerosis (MS) application and the other is for non-small cell lung cancer (NSCLC) 
application.  
MS Data  
The MS application consisted of two microarray experiments. The first one 
included chips from the experiment E-MTAB-69 stored in the ArrayExpress [15] 
repository (http://www.ebi.ac.uk/arrayexpress). All chips were hybridized on 
Affymetrix HGU133 Plus 2.0 chips. In this study, there were 26 patients with 
relapsing-remitting multiple sclerosis (RRMS) and 18 controls with neurological 
disorders of a non-inflammatory nature. The second dataset was provided by the sbv 
IMPROVER challenge in the year of 2012 [16], which is accessible to the participants 
on the project website (http://www.sbvimprover.com). It was hybridized on 
Affymetrix HGU133 Plus 2.0, and there were 28 patients with RRMS and 32 normal 
controls.  
NSCLC Data 
Microarray data used in the study are those deposited under accession numbers 
of GSE10245, GSE18842, GSE2109 (these three as the training set), and GSE43580 
(the test set) in the Gene Expression Omnibus (GEO) repository. All experiments 
were hybridized on Affymetrix HGU133Plus 2.0 chips.  
Gene Sets  
Gene sets were downloaded from the Molecular Signatures Database 
(MSigDB) [17]. In this study, we only considered c5 category. This category includes 
gene sets annotated by Gene Ontology (GO) terms. The current version (version 4.0) 
of MSigDB c5 category included 1,454 gene sets.  
Pre-processing Procedures   
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Raw data of E-MTAB-69 were downloaded from the ArrayExpress repository, 
and expression values were obtained using the fRMA algorithm [18] and 
normalization across samples was carried out using quantile normalization. The 
resulting expression values were on the log2 scale. When there were multiple probe 
sets representing the same gene, the one with the largest fold change was chosen. Raw 
data of the second set were downloaded from the sbv challenge website, and were 
separately pre-processed in the same way. 
Raw data (CEL files) of all NSCLC data sets were downloaded from the GEO 
repository, and expression values were obtained using the fRMA algorithm [18]. 
Since the training set included data from different microarray experiments, the 
COMBAT algorithm (http://www.bu.edu/jlab/wp-assets/ComBat/Abstract.html) was 
used to eliminate batch effects. Again, the training set and the test set were 
pre-processed separately.    
Statistical Methods  
SAMGSR  
SAMGSR extends a pathway analysis method called significance analysis of 
microarray-gene set (SAMGS) [19] to identify the ‘core’ subset for each significant 
gene set. In SAMGS, the following functional score is defined, 
SAMGSj = di2
i=1
| j|
∑ , di = (xd (i)− xc (i)) / (s(i)+ s0 )  
where di is the SAM statistic [12] and calculated for each gene involving in gene set j, 
xd (i)  and xc (i) are the sample averages of gene i for the diseased and control group, 
respectively. Parameter s(i) is a pooled standard deviation that estimated by pooling 
all samples together, while s0 is a small positive constant used to offset the small 
variability in microarray expression measurements, and |j| represents the number of 
genes within gene set j. A gene set’s significance is estimated using a permutation test 
by perturbing phenotype-labels. 
 For each significant gene set identified by SAMGS, the additional reduction step 
of SAMGSR partitions the entire set S into two subsets: the reduced subset 
Rk including the first k genes and the residual one Rk for k=1,…, |j| by ordering the 
genes inside the set S decreasingly based on the magnitude of di. Then the 
significance level of Rk was evaluated. That is, let ck be the SAM-GS p-value of Rk , 
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the iteration stops when ck is larger than a pre-determined threshold for the first time. 
In our applications, we consider ck as a tuning parameter, and its optimal value is 
determined using a 5-fold cross-validation. Figure 2 provides a graph illustration on 
the SAMGSR algorithm.   
Statistical Metrics 
As in previous study [20], we use four metrics - Belief Confusion Metric (BCM), 
Area Under the Precision-Recall Curve (AUPR), Generalized Brier Score (GBS), and 
misclassified error rate to evaluate the performance of a resulting gene signature. Our 
previous study and the references therein described those metrics in details. Briefly, 
they all range from 0 to 1. For BCM and AUPR the closer to 1 the better a classifier is, 
whereas the direction is opposite for GBS and misclassified error rate.  
Besides these predictive performance statistics, we additionally include the Rand 
index to evaluate the stability or robustness of the resulting signatures. With k runs of 
an algorithm, Rand index is defined as  
Rand = 2k(k −1)
(gsi ,gsj )
(gsi,gsj )j=i+1
k
∑
i=1
k−1
∑  
where ∩ represents the size of intersection between two gene lists and ∪ represents 
the size of union between two gene lists gsi and gsj obtained from the ith and jth runs. 
Certainly, Rand index can be defined at the level of pathways by replacing the gene 
lists with the pathway lists.  
Statistical Language and Packages 
All statistical analysis was carried out in the R language version 3.1 
(www.r-project.org).  
 
Results and Discussion 
Weight Construction and Weighted SAMGS Statistic   
As described in the Introduction section, SAMGSR assumes that the number of 
gene sets within which a specific gene is contained is highly correlated with the 
pathway connectivity, namely, the more number of such gene sets is, the more 
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number of other genes is connected to this gene. From the scatterplot (Figure 3), we 
found the correlation between the number of gene sets and the connectivity among 
genes is only moderate, indicating that SAMGSR does not fully account for 
connectivity information.  
To tackle this drawback of SAMGSR, we propose to combine a weight 
constructed on the basis of connectivity information with the SAMGS statistic. 
Specifically for G genes under consideration, a G×G adjacency matrix is defined. Its 
ij component aij equals to 1 if genes i and j are connected, 0 otherwise. Because here 
we only consider an undirected pathway connectivity diagram, this adjacency matrix 
is symmetric. Then the connectivity weight for gene i is defined as,    
wi = aij,
j=1,...,G
∑ aii =1  
the connectivity information was retrieved from the protein-to-protein interaction (PPI) 
information provided by Human Protein Reference Database (HPRD). The PPI 
information was downloaded from the HPRD webpage (www.hprd.org), and then the 
adjacency matrix among genes was calculated using the R software.   
In our proposed procedure, we include each gene’s weight in its SAM statistic to 
obtain so-called weighted SAM and weighted SAMGS statistics and then replace 
SAM/SAMGS with their weighted counterparts to carry out pathway selection 
followed by individual gene selection. The proposed method is referred to as 
weighted-SAMGSR herein. In Fig 2, the definition of weighted SAMGS statistics and 
where they replace SAMGS statistics are presented. Within each specific pathway, 
SAMGSR ranks genes based on their SAM statistics and discards gene connectivity 
information completely. In contrast, the weighted-SAMGS algorithm weighs the 
genes with high connectivity more importantly. This is motivated to better detect 
‘driving’ genes that are highly connected to other genes but have subtle expression 
differences to be selected increases by this means. In following subsections, we apply 
the weighted-SAMGSR algorithm to both simulated and real-world data.  
In both SAMGSR and weighted-SAMGSR algorithms, ck is regarded as a tuning 
parameter that determines the sparseness of the final models. Its optimal values are 
determined via 10-fold CV by randomly dividing the whole training dataset into 10 
roughly equal-sized folds. We apply either SAMGSR or weighted SAMGSR to 9 of 
these folds and verify their performance on the held-out fold. This step is repeated for 
each of the 10 folds as the held-out fold, and then the error rate is calculated. We then 
take the optimal ck value and apply SAMGSR or weighted SAMGSR to the whole 
training dataset to select genes in the final models, whose performances are evaluated 
using the independent test set. Of note, since for the SAMGSR methods the classifiers 
are not automatically produced along with the process of feature selection, we fitted 
support vector machine (SVM) models to estimate the corresponding coefficients of 
	   8	  /	  19	  
	  
the selected genes. 
Simulated Data    
Here, two simulations were used to characterize the weighted-SAMGSR 
algorithm and make comparisons with the SAMGSR algorithm. Here, we randomly 
chose 5 gene sets in the MSigDB c5 category. There are approximately 1000 genes 
inside these 5 gene sets. In the first simulation, we simulated the gene expression 
profile as independent random variables with a standard normal distribution and the 
sample size was 60. Then we simulated another set of normally distributed random 
variables and used it as the test set. In the second simulation, the observed expression 
values of the integrated NSCLC data were used to train the final model. The 
expression values were further normalized to have means of zeros and standard 
deviations of ones. The expression values of GSE43580 were used to test the final 
model and evaluate its performance.  
 We chose two genes—HDAC1 and GNAS as the relevant genes and simulated 
the case and control groups using the following logit function,  
logit2vs1 = 0.37XHDAC1 − 0.86XGNAS 	  
because HDAC1 has the higher connectivity, its coefficient was set as being smaller 
than that of GNAS. The simulation results are presented in Table 1.    
Overall, the weighted-SAMGSR algorithm outperforms the SAMGSR algorithm. 
Namely, the weighted-SAMGSR algorithm has a substantially higher probability to 
identify HDAC1 whose signal is about 1.5 times weaker than GNAS and has better 
performance statistics in these two scenarios. Therefore, constructing the weights 
based on genes’ topology information and incorporating those weights with the 
SAMGS statistics improve upon the feature selection capacity of SAMGSR.   
Real World Application 
Previously, we applied SAMGSR to one set of multiple sclerosis (MS) data and 
showed that it possesses the feature selection trait, indeed [21]. In this study, we use 
the MS dataset again to evaluate if weighted-SAMGSR is superior to SAMGSR after 
accounting for the additional connectivity information among genes.   
MS Data  
MS is the most prevalent demyelinating disease and the primary cause of 
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neurological disability in young adults [22]. Here, we analyzed a set of MS real-world 
data to explore the discriminative capacity of expression profiles to separate MS 
patients from controls, and to characterize the proposed weighted SAMGSR method.  
The results are presented in Tables 2 and 3. In Table 2, we observe the selected 
pathways by SAMGSR and weighted SAMGSR with high frequencies differ 
completely. On the level of individual genes, there are 6 overlapped genes. According 
to the genecards (www.genecards.org) database, two genes – POLD1 and MRE11A 
among these 6 genes are directly related with MS. In this application, weighted 
SAMGSR outperforms SAMGSR in terms of predictive performance, stability, and 
the number of directly related genes.  
 NSCLC Data (>2 groups comparison) 
Both the SAMGSR algorithm and the weighted SAMGSR algorithm can be 
adopted directly to deal with the multiple classes (>2 groups). Here, we used a set of 
NSCLC data to showcase this. In this application, the patients were categorized into 
four classes according to their respective histology subtypes and stages, i.e., 
adenocarcinoma at stage I (AC-I), adenocarcinoma at stage II (AC-II), squamous cell 
carcinoma at stage I (SCC-I), and squamous cell carcinoma at stage II (SCC-II). To 
classify on these four groups, we applied both SAMGSR algorithms twice—one for 
the subtype segmentation and one for the stage segmentation. Then the final posterior 
probabilities are P(AC-I)= P(AC)×P(stage I), P(AC-II)= P(AC)×P(stage II), 
P(SCC-I)= P(SCC)×P(stage I), and P(SCC-II)= P(SCC)×P(stage II), respectively. The 
results are given in Table 4.            
Similar to the results from the sbv Lung cancer (LC) challenge [23], the 
segmentation between stages is not achievable whereas the segmentation between 
subtypes is good. Nevertheless, both SAMGSR algorithms identify more than 300 
genes for the subtype segmentation while other studies had obtained similar 
performance using just one [24] or several genes[20]. We contribute this to the fact 
that SAMGSR is a filter method [25] that ignores the feature dependencies and thus 
tends to introduce all highly correlated features to the true relevant ones into the final 
model.  
By accounting for the connectivity among genes, weighted SAMGSR 
outperforms SAMGSR in both applications, which is consistent with the results from 
the simulated data. Nevertheless, it is observed that such superiority differs in the two 
applications—being substantial in the MS application whereas marginal in the 
NSCLC application. This may be attributable to that many cancers are under intensive 
investigation and may be better curated in the major pathway databases. Therefore, 
the genes inside one specific pathway might be more likely to function together given 
the performance of SAMGSR in the NSCLC application is already good. In contrast, 
in the MS application the performance of SAMGSR is substantially inferior to that of 
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those top 3 teams in the sbv challenge. In this case the extra information of gene 
connectivity becomes more valuable and makes the weighted SAMGSR algorithm 
comparable to the third team in this sub-challenge.      
Conclusions 
Although SAMGSR is a pathway-based feature selection algorithm in nature, it 
treats all genes inside one pathway equally and assumes those ‘core’ genes in the 
pathway co-function together to regulate biological processes. To tackle its major 
drawback of discarding the gene topology knowledge completely, we propose a 
weighted extension to SAMGSR by creating the weights based on the connectivity 
among genes and combining those weights with the SAMGS statistics. Using 
simulations and real-world applications, we demonstrated that this weighted version 
of SAMGSR outperforms the original SAMGSR algorithm. In addition, the weight 
construction is very straightforward and has added no extra computing burden to the 
algorithm. Therefore, the weighted SAMGSR algorithm is preferred over the 
SAMGSR algorithm.  
Pathway-based feature selection algorithms have become a topic of increasing 
interest in the field bioinformatics currently. Indeed, incorporating additional 
meaningful information does facilitate feature selection [26]. Nevertheless, the 
pathway knowledge is far from completeness and thus is subject to changes and errors, 
which limits the use of those pathway-based methods in practice. To address this, we 
suggest to analyze the real-world data with both gene-based methods and 
pathway-based methods and to explore if the pathway knowledge is informative for 
the specific application.    
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Tables and Figures  
Table 1. Simulation results  
 Training set Test set 
Method (Size1) HDAC1(%) GNAS(%) Error (%) GBS BMC AUPR 
A. Simulated from 60 independent normal-distributed random variables  
SAMGSR (3.8) 19 100 16.5 0.118 0.733 0.921 
W-SAMGSR (6.23) 65 100 13.2 0.101 0.755 0.948 
B. Simulated based on the NSCLC data  
SAMGSR (3.94) 0 100 44.5 0.256 0.517 0.550 
W-SAMGSR (6.28) 77 100 40.5 0.241 0.534 0.621 
Note: W-SAMGSR stands for weighted-SAMGSR; 1 stands for average the number of genes selected 
by either SAMGSR or W-SAMGSR over 100 replicates. 
Table 2. The selected pathways and genes on MS data    
 Pathways with high frequency (frequency %)  Genes (frequency %) 
SAMGSR  DNA Directed DNA Polymease Activity (100%)  
DNA Polymease Activity  (90%)  
COVALENT_CHROMATIN_MODIFICATION (70%) 
HISTONE_MODIFICATION (70%) 
 
Stability=14.04% 
POLD4(100%) POLD1(80%) 
PHB(80%) GPAA1(70%) 
PIGT(70%) DPM3(70%) 
MRE11A(60%)   PI4KB(60%)  
  
Stability=12.83%  
Weighted 
SAMGSR  
DNA_RECOMBINATION(70%) 
LIPOPROTEIN_BIOSYNTHETIC_PROCESS (70%) 
NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS(70%)     
PROTEIN_AMINO_ACID_LIPIDATION (70%) 
DEPHOSPHORYLATION(60%)  
INOSITOL_OR_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY (60%) 
LIPOPROTEIN_METABOLIC_PROCESS(60%) 
PROTEIN_C_TERMINUS_BINDING (60%) 
 
Stability=15.76 % 
MRE11A(90%) PTPRC(80%)    
BRCA1(70%)     ATM(70%) 
CHAF1A(70%)   PIGT(70%) 
GPAA1(70%)  PI4KB(70%)        
PEX16(60%)    POLD1(60%)    
POLD4(60%)  PPP1CA(60%)    
 
 
 
Stability=14.03%  
Note: Gene symbols in bold are those overlapped genes by SAMGSR and weighted SAMGSR; 
gene symbols  
      
Table 3. Performance statistics of selected genes on MS data   
 Training set (10-fold CV results)  Test set 
A. Performance of SAMGSR and weighted SAMGSR 
Method (n)  Error (%) GBS BCM AUPR Error (%) GBS BCM AUPR 
	   15	  /	  19	  
	  
SAMGSR (52)  34.09 0.244 0.570 0.645 46.67 0.465 0.501 0.725 
W-SAMGSR (25) 31.82 0.191 0.611 0.771 43.33 0.341 0.564 0.860 
B. Comparison with other feature selection algorithms  
LASSO (30) 34.09 0.275 0.632 0.672 46.67 0.377 0.499 0.747 
Penalized SVM(11) 47.73 0.406 0.534 0.630 45 0.569 0.431 0.555 
C. Performance for the top 3 teams in sbv MS sub-challenge (among 54 teams)  
Study (size) Training data used/Method used Error (%) GBS BCM AUPR 
Lauria’s (n>100) E-MTAB-69/ Mann-Whitney test, then use top 
α % of the selected genes and Cytoscape to 
get the clusters on the test set 
-- -- 0.884 0.874 
Tarca’s (n=2) GSE21942 (on Human Gene 1.0 ST)/LDA  -- -- 0.629 0.819 
Zhao’s (n=58) 7 other data and E-MTAB-69/Elastic net 30 -- 0.576 0.820 
Note: W-SAMGSR: weighted SAMGSR; LDA: linear discrimination analysis. --: not available. 
Lauria’s Tarca’s and Zhao’s studies [27–29] are the 3 best studies in the sbv MS sub-challenge. 
Table 4. Performance statistics of selected genes on NSCLC test data 
 Training set (5-fold CV results)  Test set 
A. Performance of SAMGSR and weighted SAMGSR 
Method (n)  Error (%) GBS BCM AUPR Error (%) GBS BCM AUPR 
SAMGSR (30) 1 40.7 0.279 0.377 0.462 51.3 0.348 0.407 0.486 
W-SAMGSR (27)1 37.2 0.276 0.378 0.453 51.3 0.345 0.405 0.492 
B. Comparison with other feature selection algorithms  
LASSO (95) 38.6 0.281 0.458 0.483 52.7 0.395 0.456 0.485 
pSVM (>100) 42.8 0.370 0.344 0.428 53.3 0.433 0.385 0.397 
C. Performance for the top 3 teams in sbv NSCLC sub-challenge (among 54 teams)  
Study (size) Training data used/Method used Error (%) GBS BCM AUPR 
Ben-Hamo’s (23) GSE10245, GSE18842, GSE31799/PAM 49.3 -- 0.48 0.46 
Tarca’s (25) GSE10245, GSE18842, GSE2109/ 
moderated t-tests+LDA 
-- -- 0.459 0.454 
Tian’s (66) GSE10245, GSE18842, GSE2109/TGDR in 
hierarchical way  
53.3 0.374 0.440 0.471 
Note: W-SAMGSR: weighted SAMGSR; pSVM: penalized support vector machine (SCAD penalty 
term); LDA: linear discriminant analysis; PAM: partitioning around medoid; TGDR: threshold gradient 
descent regularization; 1The sizes of final model for the stage segmentation because the results for the 
subtype segmentation for both algorithms are identical (but the final size>300). Ben-Hamo’s study 
[24],Tarca’s study [28]and Tian’s study [30] are the 3 best studies in the sbv LC sub-challenge.	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Figure 1. Three categories of pathway-based feature selection algorithms. The 
filter and embedded methods are two typical types for the gene-based feature 
selection algorithms. As defined by [25], filter methods access the relevance of 
features by calculating some functional score while embedded methods search for the 
optimal subset simultaneously with the classifier construction.  
Category/description   Property  Pathway topology 
information
Examples [Ref.] 
Penalty: add an extra penalty 
term which accounts for the 
pathway structure to the 
objective function, then 
optimize the resulting function 
to get the final gene subset  
Embedded feature selection 
methods, carry out feature 
selection and coefficient 
estimation simultaneously, 
moderate to heavy computing 
burden
Need the pathway 
topology information 
for all genes, e.g., 
are they connected 
and the distance 
between them
Net-Cox [Zhang et 
al, 2013]  
netSVM [Chen et al, 
2011]
Stepwise forward: order 
genes based on one specific 
statistic, and then add gene 
one by one until there is no 
gain  on the pre-defined 
score. 
Usually filter methods,  the 
beneath concepts and theory 
are simple. However, they also 
inherits the filter methods’ 
drawbacks of inferior model 
parsimony and thus high false 
positive rate. 
Usually ignore the 
pathway topology 
information, the 
decision hinges 
mainly on the 
genes’ expression 
values 
SAM-GSR  
[Dinu et al, 2009]  
SurvNet  [Li et al, 
2012] 

Weighting: create some kind 
weights according to the 
pathway knowledge and then 
combine with other feature 
selection methods to identify 
the relevant genes 
With different weights, the 
chance of  those “driving” genes 
with subtle change being 
selected increases. However, if 
the estimated weights subject to 
big biases, the resulting model 
might even be inferior to those 
without weights.  
Account for the 
pathway topology 
information. 
RRFE [Johannes et 
al, 2010] 
DRW [Liu et al, 
2013]
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Figure 2. Diagrams to elucidate both SAMGSR and weighted SAMGSR 
algorithms. 
."."."
"""""GS"1"
"
G1,"…,"""
G|gs1|"
"
"
"
"
"
"
G1,…,"
G|r1|"

"
"""""""GS#|GS|
 
 
 
 
 
 
 
 
 
 
 
"""""""
""GS"k"
"
""G1,…"
"G|gsk|"
"
"
"
"
"
"
"

For#each#selected#pathway,#using#
SAM:GSR#to#get#its#corresponding#
core#gene#subset
""""""RGS"1
"
"""
"""G1,…"
"""G|rk|"
"
""""""RGS"k
"""""""""""#GS1####################################################.##.##.
Gene#signature:#the#union#of#genes#within#these#k#reduced#gene#subsets#
"
"""""""""""""""""""""""""""""""#
######################################SAM:GS#step:#using#SAM:GS#staBsBc#and#permutaBon#tests#to#select#pathways#SAM −GSj = SAMi2
i=1
| j|
∑
SAMi =
(xd (i)− xc (i))
(s(i)+ s0 )
wSAM −GSj = wiSAMi2
i=1
| j|
∑
wSAMi =
wi (xd (i)− xc (i))
(s(i)+ s0 )
|GS|:""the"number"of"pathways""
"
"
""""""""""""""""""""""""""""""""""
"
"
"
"
k:"the"number"of"significant"
pathways"selected"by"SAMCGS""
"
|gsi|:"the"number"of"genes"inside"
pathway"i""
"
"
|rj|:"the"number"of"genes"inside"
the"reduced"gene"subset"j"
A."Diagrams"on"SAMGSR"and"weighted"SAMGSR"algorithms"
B.##Defini)on#of#pathway#topology4based#weights
2
3
8
1
4
5
6
7
Genes#
A#pseudo4pathway#with#8#genes#
Adjacency#matrix#
g1 g2 g3 g4 g5 g6 g7 g8 w
g1 1 1 0 0 0 0 0 1 3
g2 1 1 1 0 0 0 0 0 3
g3 0 1 1 1 1 1 0 1 6
g4 0 0 1 1 0 0 0 0 2
g5 0 0 1 0 1 1 0 0 3
g6 0 0 1 0 1 0 1 0 3
g7 0 0 0 0 0 1 1 1 3
g8 1 0 1 0 0 0 1 1 4
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Figure 3. Scatterplot of the number of gene sets involved versus the gene 
connectivity. ρ is the estimated Spearman correlation coefficient between the number 
of gene sets involved and (1+the number of connected genes)   
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